Parkinson's disease (PD) is a common neurodegenerative disorder that involves the 
Introduction
Parkinson's disease (PD) is a progressive age-related movement disorder with a prevalence of approximately 2% in the population aged over 65 (1) . Clinically, it is characterized by bradykinesia, muscular rigidity, resting tremor and postural instability, which are due to the progressive and selective loss of dopaminergic neurons in the substantia nigra pars compacta. Insoluble protein aggregates known as Lewy bodies (LBs) are seen in the cytoplasm of dopaminergic neurons and other subcortical and cortical structures. LBs are fibrillary inclusions that mainly consist of a-synuclein and ubiquitin (2) .
Although the etiology of the majority of PD cases is still unknown it is likely to be a combination of genetic and environmental factors. The genetic loci and genes linked with familial PD that account for less than 10% of all cases of PD (3), have provided tremendous insight into the pathogenesis of this disorder by elucidating some of the molecular pathogenic mechanisms (4) (5) (6) . Recently we reported the cloning of the DJ-normal metabolism of dopamine in itself might be responsible for high basal levels of oxidative stress in the substantia nigra, due to auto-oxidation of dopamine, the subsequent semiquinone formation, and polymerization through which radical species are produced. The hydroxyl radical produced can damage proteins, nucleic acids and membrane phospholipids, potentially leading to cellular degeneration.
By studying two families from genetically isolated communities in the Netherlands and Italy, two mutations in the DJ-1 gene were found to be associated with autosomal recessive early-onset PD (7) . In the Dutch family, a large homozygous genomic deletion removes approximately 14 kb of genomic DNA, including the first 5 exons of DJ-1 and approximately 4kb of promoter sequence. The result of this mutation is that the expression of DJ-1 is completely abolished. In the Italian family, a homozygous point mutation was identified, resulting in the substitution of a highly conserved leucine residue at position 166 of the DJ-1 protein by a proline. DJ-1 is ubiquitously expressed in human tissues (7, 17) and is present in both the nucleus and cytoplasm of mammalian cells. Although its exact biological function is still largely unknown, previous studies suggest several putative roles for DJ-1. In particular there is evidence that DJ-1 might play an important role in the posttranscriptional control of gene expression. Hod et al. (18) identified DJ-1 as a regulatory subunit (RS) of an unknown 400 kDa complex (RBP) that contains an RNA-binding activity, and demonstrated that the purified recombinant RS has the capacity to bind the complex and inhibit the RNA-binding activity. DJ-1 further acts as a positive transcriptional co-regulator of the androgen receptor (AR) by preventing PIASxa/ARIP3 (androgen receptor interacting protein 3) and DJBP (DJ-1 binding protein) from binding to AR (17, 19) . PIASxa/ARIP3 is a member of the PIAS (Protein Inhibitor of Activated STAT) protein family that not only interacts with SUMO-1 but also functions as an E3 type SUMO protein ligase (20) . PIASxa was first characterized as an AR binding protein that specifically down regulates the transcriptional activity of the AR. DJ-1 directly binds to the AR binding region of PIASxa thereby absorbing PIASxa from the AR-PIASxa complex. DJBP directly binds to both DJ-1 and AR in a testosterone-dependent manner and it negatively modulates the AR transcription activity by recruiting histone-deacetylase complexes.
DJ-1 antagonizes this inhibition by abrogation of the complexes thereby restoring AR activity.
Other studies suggest that DJ-1 is a protein responsive to oxidative stress resulting from exposure to H 2 O 2 or the pesticide paraquat (21, 22) and that might function as an indicator of oxidative stress state in vivo since it is converted into a variant with a lower pI (pI 5.8) on 2D gels in response to small amounts of reactive oxygen species (ROS) produced during aerobic metabolism in murine cells and tissues (22) .
We have proposed a "loss of function" mechanism to explain the pathogenicity of both DJ-1 mutations in the Dutch and Italian families (7); however the molecular mechanism underlying the DJ-1 L166P mutation needs to be clarified. Based on the structure of the PH1704 protease from Pyrococcus horikoshii (23) we predicted a molecular model of DJ-1 and assumed that DJ-1 adopts the same α/β sandwich structure as PH1704. The latter was found to form a hexameric ring structure, which can be regarded as a trimer of dimers with the active sites in the dimerization regions.
According to our model, L166P, is placed right in the middle of a C-terminal helix, providing a straightforward structural explanation for the mutant's dysfunction:
proline is a strong helix breaker and its presence in the mutant is therefore likely to destabilize the terminal helix, which forms part of the trimerization region, and provides a scaffold for the loop formed by residues S155 to P158 which is part of the active site cleft. The general pattern of salt bridges and hydrophobic packing in the trimerization region of PH1704 is conserved in the DJ-1 model, which makes it likely that DJ-1 also forms higher aggregates (7) . Therefore, here we investigated this hypothesis and demonstrate that while DJ-1 WT protein is likely to form dimers, in contrast DJ-1 L166P forms higher order structure. The suggested structural changes and the resulting aberrant complex formation might have serious consequences on the normal biological function of DJ-1.
In addition we report that the expression of DJ-1 L166P in patient lymphoblasts cells is extremely low compared to DJ-1 WT in control samples suggesting that an abnormal turnover of the mutant protein might play an important role in the pathogenic mechanism as well.
Results

Intracellular localization of DJ-1 L166P
DJ-1 WT shows diffuse cytoplasmic and nuclear immunoreactivity in several mammalian cells including COS, HeLa and PC12 cells (7, 17, 18, 24) . DJ-1
L166P
, in transfected COS and PC12 cells, has a similar uniform nuclear staining, whereas the cytoplasmic staining appeared mostly co-localizing with mitochondria (7) . Since in the DJ-1 molecular model, L166 is placed right in the middle of a carboxyl-terminal helix, we wanted to rule out the possibility that the mitochondrial localization was a direct consequence of using a C-terminal tagged construct. We therefore transfected (Fig 2A) . This is consistent with DJ-1 WT being a dimer. In contrast, DJ-1 L166P is present in fractions 19 and 20 (Fig 2A) , corresponding with the elution profile of the protein marker BSA (68 kDa). These results would suggest that DJ-1 L166P forms higher order structures.
Since these experiments were performed using an over-expression system, we further characterized endogenous DJ-1 in lymphoblast cells ( Fig. 2B ) originated from the patient carrying the homozygous L166P point mutation and from a healthy control individual. Once again DJ-1 L166P was eluted one fraction earlier than DJ-1 WT , strengthening therefore the suggestion that DJ-1 in normal conditions might assume a dimer conformation and that the L166P mutation affects the structure in such a way that DJ-1 L166P forms larger protein complexes.
In order to study the strength of the potential DJ-1/DJ-1 interaction, the experiments were repeated using high salt lysis buffers. Two different salt concentrations were tested: 500 mM and 1 M NaCl (Fig 2C) , respectively. DJ-1 wild type and mutant physiological profiles were not affected by the 500mM NaCl treatment, suggesting that DJ-1 interactions are strong enough to hold even in the presence of high salinity levels. However, in the presence of 1M NaCl both wild type and mutant DJ-1 run as a 68kDa protein complex. It appears that very high non-physiological salt concentrations induced the wild-type protein to behave as the mutant protein forming higher order structure.
L166P does not affect DJ-1 interaction with PIASxa/ARIP3 protein
Since there is an effect of the L166P mutation on cellular localization and complex formation of DJ-1, we then tested whether known protein interactions would be /GFP and a-synuclein/V5 constructs. Cytoplasmic lysates were fractionated by gel filtration using physiological conditions. The collected fractions were visualized with anti-GFP and anti-V5 antibodies to detect DJ-1 and a-synuclein, respectively. As it was previously shown by Xu et al. (27) , a-synuclein forms 54-83 kDA soluble protein complexes and this pattern essentially does not change after DJ-1 coexpression, (Fig.4) To exclude the possibility that this finding was artificially determined by the C- We therefore performed quantitative RT-PCR experiments on total RNA isolated from lymphoblast cells of the L166P patient and control samples using DJ-1 primers that span the exons 3 and 5 and exons 5 and 6. Primers specific for the HPRT gene were also included in the assay to provide a normalization control for each sample.
We found no significant difference in DJ-1 transcription levels between the patient and control samples (data not shown).
To study possible differences in the stability of the normal and mutated protein, we 
Discussion
The results of our analyses of DJ-1 WT by gel fractionating assays on either lymphoblast cells and over expression cellular systems strongly suggest DJ-1 WT forms dimers as was predicted from our molecular model (7) . We also demonstrate that DJ-1 L166P is present in a higher order protein complex and that its expression levels in transfection studies and patients lymphoblasts are very low compared to the wild type protein.
The L166 residue is highly conserved in evolution among the DJ-1 proteins and based on the sequence homology between DJ-1 and the PH1704 from Pyrococcus horikoshi we previously suggested that the L166 amino acid is located right in the middle of a carboxyl terminal helix. This carboxyl terminal helix is thought to be involved in the formation of DJ-1 high order structures (7) . Therefore the change of the 166 residue from leucine to proline might have a destabilizing effect forcing the dimer to assume a different structure as compared to the wild type protein. The shift in molecular size observed for the mutant protein in our gel filtration experiments, might be a direct consequence of protein misfolding that affects migration of the protein under native conditions. Alternatively, the extended elution pattern might be explained by DJ-1 present as a monomer forming complexes with other unidentified protein. Such binding would be quite strong, as it was not disrupted under high salt conditions.
Although it might be relevant to determine the exact structure of DJ-1 L166P the structural change might not be the crucial event for the disease pathogenesis as we have demonstrated that the mutation does not alter the known protein interaction with PIASxa/ARIP3.
Recently, two independent studies reported the crystal structure of DJ-1 revealing that the wild type protein indeed forms dimers and that this dimer formation is likely correlated with DJ-1 biological function (28, 29) , in agreement with our results. Any attempt to obtain the crystal structure of the mutant protein failed, but light scattering experiments showed that it might exist in solution as monomer (28) .
Interestingly, in our earlier study (7) In this context then we might also reinterpret the results demonstrating the interaction of DJ-1 L166P with PIASxa/ARIP3, particularly if the interaction is dose-dependent.
Low level of expressed DJ-1 might not be sufficient to efficiently absorb PIASxa from the AR-PIASxa complex, consequently leading to down regulation of the AR.
Furthermore the potential antioxidant property and chaperone activity of DJ-1 would be also jeopardized by the high instability demonstrated by the mutant protein.
In conclusion, our results would suggest that the reduced stability of DJ-1 L166P
could well explain the loss of function proposed for the L166P mutation. The dramatic reduction observed in the steady state level of DJ-1 would consequently impair the protein capability to perform its normal biological functions leading therefore to Parkinsonism.
Material and Methods
Plasmids and their construction
DJ-1
WT /V5 and DJ-1 L166P /V5 have been previously described (7) . Coding sequence of DJ-1, DJ-1 L166P and alpha-synuclein were amplified by PCR and cloned in pcDNA3.1/CT-GFP-TOPO and pcDNA.3.1/V5-His TOPO (Invitrogen), respectively.
For the untagged constructs DJ-1 WT and DJ-1 L166P cDNAs were amplified by reverse transcriptase treated total RNA from a control sample and from a patient carrying L166P mutation by using the following forward and revers primers: 5' gggtgcaggcttgtaaacat 3' and 5'tgacttccatacttccgaa 3'. PCR products were cloned in TOPO TA cloning vector (Invitrogen), and ECO RI fragments were then transferred to pcDNA3.1 expression vector (Invitrogen). Fidelity of the constructs was verified by sequencing using the Big Dye terminator ver.3 (Applied Biosystems). The longest tau isoform containing four microtubules-binding repeats (4R tau) cloned into pcDNA3.1 has been described elsewhere (38) .
pFLAG-PIASxa-ARIP3 and pFLAG-PIASxa-ARIP3 ∆347-418 , were kindly provided by Jorma J. Palvimo (26) .
Antibodies
The following primaries antibodies were used: mouse monoclonal anti-V5 antibody from Invitrogen, mouse monoclonal anti-FLAG antibody M2 from Sigma, mouse monoclonal against green fluorescent protein from Clontech, mouse monoclonal anti tau (H-7) from Innogenetics, mouse monoclonal anti DJ-1 from Stressgen, mouse monoclonal anti a-tubulin from Sigma and rabbit polyclonal anti DJ-1 SN1132 was developed and characterized by us as described elsewhere (25) . Secondary antibodies:
horseradish peroxidase-conjugated anti rabbit and anti-mouse IgG were purchased from Amersham and goat anti mouse FITC-conjugated, and goat anti rabbit TRITCconjugated were from Sigma. Lysates were homogenized by sonication and then centrifuged at 13000g at 4ºC for 10 min to obtain a cytoplasmic supernatant. Cytoplasmic lysate (2/3) was injected into the SMART system and the protein profile was monitored at 280nm with a column flow rate of 50 µl/min. Fractions (50 µl each) were collected separately.
Gel electrophoresis and immunoblotting
Proteins present in total lysates and protein fractions were released in 2x sodium for HPRT. PCR reactions were prepared by using qPCR Core Kit for SYBR Grenn from Eurogentec and the iCycler iQ termocycler from Biorad.
Immunofluorescence
The day before transfection, COS-1 cells were seeded on glass coverslips. /V5 lysated by using 150 mM (A) and 1 M NaCl (C), respectively. B: elution fractions from lymphoblast cells from a healthy control (2.5x10 6 ) and from the Italian patient carrying the DJ-1 L166P mutation (5x10 6 ) lysated in lysis buffer containing 150 mM NaCl. DJ-1 was detected by using SN1132 and V5 antibodies. , respectively.
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